References
- Brewer A, Minatelli J, Plowman J, et al. 5-(N-Phenylcarbox-amido)-2-thiobarbituric acid (NSC 336628); A novel antitumor agent. Biochem Pharmacol 1985; 34: 2047–2050
- Glover A, Chun H, Kleinman L, et al. Merbarone: An antitumor agent entering clinical trials. Invest New Drugs 1987; 5: 137–143
- Dimaggio J, Warrell R, Muindi J, et al. Phase I clinical and pharmacological study of merbarone. Cancer Res 1990; 50: 1151–1155
- Carter S, Comis R. Integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocar-cinoma. Cancer Treat Rev 1975; 2: 193–214
- Moertel C. Chemotherapy of gastrointestinal cancer. Clin Gastroenterol 1976; 5: 777–793
- Crooke S, Bradner W. Mitomycin C: A review. Cancer Treat Rev 1976; 3: 121–139
- Kemmenoe B, Malspeis L. Distribution of [2-−14C]-merbarone in mice by autoradiography of whole body cryosections (abstract). Proc Am Assoc Cancer Res 1986; 27: 402
- Clinical Brochure for Merbarone. Division of Cancer Treatment, National Cancer Institute, Bethesda, MD October, 1985